Pharmaceutical Regulatory Approvals in Oman & GCC Made Simple.
Expert drug registration, CTD/eCTD dossier preparation, and market access support for pharmaceutical companies entering Oman, UAE, Saudi Arabia, and the GCC region.
Trusted by pharmaceutical companies worldwide
Your Trusted Partner for Pharmaceutical Market Access in GCC
GHR Medical Services is a specialized pharmaceutical regulatory consulting firm helping global pharma companies achieve compliance-ready approvals and successful market entry across Oman and the GCC region.
With 6+ years of regulatory affairs experience in Oman and 10+ years of market experience, our team understands both the regulatory complexities and commercial realities of bringing medicines to patients who need them.
Comprehensive Drug Registration & Market Access Support
From initial regulatory strategy to commercial distribution, we provide end-to-end support for your pharmaceutical products across Oman and the GCC region.
Regulatory Approvals
End-to-end pharmaceutical product registration and drug approval support for Oman MOH and GCC regulatory authorities.
Dossier Preparation
CTD/eCTD documentation compilation, gap analysis, and formatting excellence for regulatory submissions across GCC markets.
Regulatory Consulting
Expert regulatory affairs advisory for pharmaceutical compliance, strategy development, and authority liaison in Oman & GCC.
Regulatory Intelligence
Real-time regulatory updates, compliance change alerts, and market monitoring for pharmaceutical companies in GCC region.
Marketing Support
Go-to-market strategy, product positioning, and healthcare professional engagement for pharmaceutical launches in Oman.
Distribution Support
Pharmaceutical distribution network access to clinics, polyclinics, hospitals, and pharmacy channels across Oman.
Pharmaceutical Market Access Across the GCC Region
Deep regulatory expertise and local market presence in Oman, UAE, Saudi Arabia, and the wider GCC region.
Expert Knowledge for Pharmaceutical Compliance
India-Oman CEPA: Why 2026 is the Year Pharma Companies Should Start Moving Now
The India-Oman CEPA creates unprecedented opportunities for pharmaceutical companies. Learn why 2026 is the critical setup year and how to position your portfolio for success.
2026 GCC Pharmaceutical Regulatory Outlook: Key Changes & Trends
Comprehensive analysis of emerging pharmaceutical regulations, compliance requirements, and market trends shaping the GCC region.
CTD Dossier Preparation Best Practices for GCC Submissions
Essential guidelines for preparing compliant CTD/eCTD documentation that meets GCC regulatory authority requirements.
The GHR Advantage for Pharmaceutical Registration
Specialized GCC Expertise
6+ years focused exclusively on GCC pharmaceutical regulations. We know the nuances of each market.
Expert Leadership Team
Led by Prof. Grishma Raithatha (RA) and Pharmacist Hiren Raithatha with combined 16+ years experience.
End-to-End Support
From dossier preparation to commercial distribution, we handle every step of your market entry.
Local Market Presence
Strong relationships with Oman MOH, distributors, clinics, and pharmacy networks across the region.
Compliance-First Approach
100% focus on regulatory compliance. No shortcuts. Every submission meets authority expectations.
CTD/eCTD Excellence
Expert CTD and eCTD dossier preparation with comprehensive gap analysis and formatting.
Ready to Enter the GCC Pharmaceutical Market?
Get a free consultation with our regulatory experts. Discuss your product, timeline, and market entry strategy.